Capsida Biotherapeutics

Capsida Biotherapeutics is focused on developing innovative gene therapies using its proprietary AAV (adeno-associated virus) platform to treat various diseases

capsida.com

Biotech & Life Sciences

Sector

Seed

Stage

Biotech

Model

01Company Overview

Capsida Biotherapeutics is focused on developing innovative gene therapies using its proprietary AAV (adeno-associated virus) platform to treat various diseases.

02Backed By1 investor

WBWestlake BioPartners→

03Similar Companies